CTI BioPharma
CTIC
#5644
Rank
NZ$2.07 B
Marketcap
NZ$15.70
Share price
0.00%
Change (1 day)
32.34%
Change (1 year)

Market capitalization of CTI BioPharma (CTIC)

Last known market cap: NZ$2.07 Billion

On August 25, 2023 CTI BioPharma had a market cap of NZ$2.07 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of CTI BioPharma from 2001 to 2023

End of year Market Cap

Year Marketcap Change
2023NZ$1.89 B57.81%
2022NZ$1.20 B242.15%
2021NZ$0.35 B3.65%
2020NZ$0.33 B149.01%
2019NZ$0.13 B114.49%
2018NZ$63.41 M-60.89%
2017NZ$0.16 B-2.39%
2016NZ$0.16 B-67.04%
2015NZ$0.50 B-5.33%
2014NZ$0.53 B57.43%
2013NZ$0.33 B94.87%
2012NZ$0.17 B-39.42%
2011NZ$0.28 B-25.58%
2010NZ$0.38 B-58.45%
2009NZ$0.92 B6468.7%
2008NZ$14.1 M-88.82%
2007NZ$0.12 B-64.89%
2006NZ$0.35 B56.81%
2005NZ$0.22 B-67.09%
2004NZ$0.69 B53.55%
2003NZ$0.45 B-0.15%
2002NZ$0.45 B-76.85%
2001NZ$1.96 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
NZ$293.28 B 14,066.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$180.04 B 8,596.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
NZ$32.26 B 1,458.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$16.21 B 683.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.538 T 74,204.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$59.04 B 2,751.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
NZ$434.73 B 20,898.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland